Uniting Forces to Drive Healthcare Innovations and Elevate Patient Safety in Thailand
On September 3, 2026, Biocotton Co., Ltd. was deeply honored to be invited by Mr. Att Thongtang, CEO of Phyathai and Paolo Hospital Group, alongside Dr. Suwit Wibulpolprasert, Chairman of the Steering Committee for Driving and Scaling Thai Medical and Health Innovations into the Public Market. Together, we attended an on-site visit to observe the real-world deployment of the AI-Robotic NPI Platform, an advanced solution designed for pressure ulcer prevention at Phramongkutklao Hospital and Phyathai 3 Hospital.
The event showcased groundbreaking medical technologies co-developed by the Phyathai-Paolo Hospital Group and its network of strategic partners. A key focus was pushing these innovations toward inclusion in the National Health Security Office (NHSO) benefits package, ensuring equitable access and maximum benefit for patients nationwide.
Additionally, Nurse Manager Kittirawee Supawatdisakul, Director of Clinical Innovation Development, presented the Endoscopic Specimen Retrieval Bag, marking another significant milestone in enhancing safety standards, efficiency, and precision in surgical care.
Biocotton remains steadfast in its commitment to serving as a vital gear in advancing medical innovation. Working hand-in-hand with leading clinical experts, we strive to establish new benchmarks for patient safety and build a future of sustainable, high-quality healthcare access for all.
“Patient Safety First”
Tel. : 096-292-2149
Line ID : @biocotton
E-mail : Contact@biocotton.co.th
Photo Gallery
